Crossmark

Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine

Crossref DOI link: https://doi.org/10.1016/j.waojou.2020.100098

Published Print: 2020-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Castro-Almarales, Raúl Lázaro https://orcid.org/0000-0003-0956-7946
Ronquillo-Díaz, Mercedes

Álvarez-Castelló, Mirta

Rodríguez-Canosa, José

González-León, Mayda

Enríquez-Domínguez, Irene

Navarro-Viltre, Bárbara Ivonne

Mateo-Morejón, Maytee

Oliva-Díaz, Yunia

Ramírez-González, Wendy

Cox, Linda

Labrada-Rosado, Alexis
Funding

Funding for this research was provided by:

Styrelsen fÃ¶r Internationellt Utvecklingssamarbete

Ministry of Public Health

Ministerio de Ciencia, Tecnología y Medio Ambiente
License Information

Text and Data Mining valid from 2020-04-01

Text and Data Mining valid from 2020-04-01

Version of Record valid from 2020-01-03
More Information

This article is maintained by: Elsevier

Article Title: Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine

Journal Title: World Allergy Organization Journal

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.waojou.2020.100098

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.